Trials / Unknown
UnknownNCT04379219
Surgery Alone Versus Methotrexate Before Surgery in Cesarean Scar Pregnancy
Surgery Alone Versus Methotrexate Before Surgery in Cases of First Trimester Cesarean Scar Pregnancy: a Randomized Controlled Trial
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 56 (estimated)
- Sponsor
- Mansoura University · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
There are no universal treatment guidelines available. The ultimate purpose of the management of CSP is to simultaneously remove the pregnancy and successfully preserve the woman's fertility (Gonzalez \& Tulandi, 2017). A variety of medical and surgical treatment modalities for CSP have been reported; however, most of these are based on low-level evidence(Sun et al., 2019).
Detailed description
This will be a randomized clinical trial to evaluate the effect of administration of methotrexate before surgery in reducing bleeding, injury to bladder and ureter, operative time and removing of CSP mass.This will be in comparison to surgery alone in cases of first trimester cesarean scar pregnancy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methotrexate | giving methotrexate at least 1 w week before surgery |
Timeline
- Start date
- 2019-12-01
- Primary completion
- 2020-08-01
- Completion
- 2020-12-01
- First posted
- 2020-05-07
- Last updated
- 2020-05-07
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04379219. Inclusion in this directory is not an endorsement.